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Abstract
Background: Genome-wide linkage studies in multiple ethnic populations found chromosome 1q21-q25 was the
strongest and most replicable linkage signal in the human chromosome. Studies in Pima Indian, Caucasians and
African Americans identified several SNPs in DUSP12 and ATF6, located in chromosome 1q21-q23, were associated
with type 2 diabetes.
Methods: We selected 19 single nucleotide polymorphisms (SNPs) that could tag 98% of the SNPs with minor
allele frequencies over 0.1 within DUSP12-ATF6 region. These SNPs were genotyped in a total of 3,700 Chinese Han
subjects comprising 1,892 type 2 diabetes patients and 1,808 controls with normal glucose regulation.
Results: None of the SNPs and haplotypes showed significant association to type 2 diabetes in our samples. No
association between the SNPs and quantitative traits was observed either.
Conclusions: Our data suggests common SNPs within DUSP12-ATF6 locus may not play a major role in glucose
metabolism in the Chinese.
Background
Type 2 diabetes is a complex disease caused by both
genetic and environmental factors. Although recent gen-
ome-wide association studies have identified several novel,
possibly causative genes, the contribution of them to dis-
ease risk is still very limited [1]. Thus the genetic architec-
ture of type 2 diabetes remained largely unknown.
Previous genome-wide linkage studies in multiple ethnic
populations, including Caucasians, Chinese and Pima
Indian, showed that chromosome 1q21-q25 was the stron-
gest and most replicable linkage signal in the human chro-
mosome [2-9]. Although genome-wide association studies
show no strong association signal in this region, whether
variants harbored in this region conferred modest effect to
the disease are worthy to be analyzed.
Dual specificity phosphatase 12 (DUSP12) and activating
transcription factor 6 (ATF6) were two neighbored genes
locating on the chromosome 1q21-q23. DUSP12 is a
glucokinase - associated protein identified from rat hepatic
cDNA library through yeast two-hybrid, using glucokinase
as bait. It may participate in glycolysis in the liver and pan-
creatic beta-cell through dephosphorylation of glucokinase
in the cytoplasm [10]. ATF6 is a key sensor of endoplasmic
reticulum stress. It activates unfolded protein response
through regulating a group of genes encoding molecular
chaperones and folding enzymes [11]. Previous studies
identified several single nucleotide polymorphisms (SNPs)
in this region associated with type 2 diabetes in different
populations. Among them, rs2070150 (P145A) was firstly
identified to be associated with type 2 diabetes in Pima
Indian, while rs4579731, rs3820449 and rs10918215 were
reported later in studies focusing on Caucasians and Afri-
can Americans [12-15]. However, International Type 2
Diabetes 1q Consortium failed to detect any association
signal on DUSP12 and ATF6 in a fine mapping study in
multiethnic samples [16]. Even though, only 285 East
Asian origin samples were included in the previous studies
and no one analyzed the association between SNPs from
this region and type 2 diabetes in large Asian samples.
Therefore, we performed the present study, aiming to test
* Correspondence: wpjia@sjtu.edu.cn
Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus,
Shanghai Clinical Center for Diabetes, Department of Endocrinology and
Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,
Shanghai, PR China
Hu et al. BMC Medical Genetics 2011, 12:3
http://www.biomedcentral.com/1471-2350/12/3
© 2011 Hu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.if variants from DUSP12 and ATF6 played a role in the
genetic susceptibility of type 2 diabetes in the Chinese.
Methods
Participants
In this case-control study, we recruited 3,700 unrelated
Chinese Han subjects, including 1,892 case and 1,808
controls. All the subjects were eastern Chinese Han
ancestry, residing in Shanghai and nearby region. In the
present study, all case subjects were type 2 diabetes
patients selected from Shanghai Diabetes Institute inpa-
tient database. Control subjects were community-based
populations enrolled from the Shanghai Diabetes Studies
[17]. The inclusion and exclusion criteria for the cases
and controls were described previously [17]. Briefly, all
cases were type 2 diabetes patients defined according to
1999 WHO criteria (fasting plasma glucose ≥7.0 mmol/l
and/or 2-h plasma glucose ≥11.1 mmol/l) and were trea-
ted with oral hypoglycemic agents and/or insulin. The
control subjects were normal glucose tolerance defined
based on fasting plasma glucose <6.1 mmol/l and 2-h
plasma glucose <7.8 mmol/l. This study was approved
by the institutional review board of Shanghai Jiao Tong
University Affiliated Sixth People’s Hospital. Written
informed consent was obtained from each participant.
Clinical measurement
All subjects underwent detailed clinical investigations, as
described previously [17]. Briefly, anthropometric para-
meters such as height, weight, waist and hip circumfer-
ence (for the control subjects only) were measured. For
the control subjects, blood samples were obtained at 0
and 120 min during the oral glucose tolerance tests
(OGTTs) to measure plasma glucose and serum insulin
levels. Lipid profiles such as total cholesterol and trigly-
ceride were also obtained. Insulin resistance and pan-
creatic b-cell function were assessed by homeostasis
model assessment (HOMA) [18]. HOMA-IR = fasting
insulin × fasting plasma glucose ÷ 22.5, HOMA-B = 20
× fasting insulin ÷ (fasting plasma glucose ÷ 3.5).
SNPs selection, genotyping and quality control
We selected 19 SNPs that spanning 197 kb of DUPS12
and ATF6 region, from 10 kb 5’ upstream the DUSP12 to
2k b3 ’ downstream the ATF6. These SNPs could tag
98% of the SNPs with MAF over 0.1 derived from Hap-
Map Phase III Chinese Han database under the threshold
of r
2 ≥0.7. Among them, 7 SNPs located in the coding
region. The SNPs previously reported were either directly
genotyped or in linkage disequilibrium (LD) with geno-
typed SNPs. All the SNPs were genotyped using Seque-
nom’s MassARRAY iPLEX system (MassARRAY
Compact Analyzer, Sequenom, San Diego, CA, USA).
The key quality control requirements were: 1) sample
call rates ≥75%; 2) SNP call rate ≥85%; 3) less than two
discrepant genotypes of 100 duplicate samples; and 4)
Hardy-Weinberg equilibrium test ≥0.05 in controls and
cases respectively. After the quality control procedures of
the genotypes, 71 individuals were excluded. And one
SNP (rs3767635) failed Hardy-Weinberg equilibrium test.
The average call rate for the remaining 18 SNPs was
97.5%, and the average concordance rate based on 100
duplicate comparisons for each SNP was 99.4%. Detailed
information of the call rates and concordance rates for
the SNPs was shown in the Additional file 1 Table S1.
Statistical analyses
Observed genotypes were tested for fit to the expectation
of Hardy-Weinberg equilibrium using c
2 test. Pairwise
LD was estimated from the combined data of cases and
controls calulating |D’|a n dr
2 using Haploview (version
4.1) http://www.broadinstitute.org/haploview/haploview
[19]. Haplotype block structure was determined using
confidence interval algorithm [20] and haplotype fre-
quencies were estimated by Expectation-Maximization
a l g o r i t h m[ 2 1 ]u s i n gH a p l o v i e w (v 4.1). Allele, genotype
and haplotype frequencies for cases and controls were
compared using c
2 test or Fisher’s exact test. Odds ratios
(ORs) with 95% confidence intervals (CIs) were pre-
sented. The genotype - disease association analyses were
performed under the additive model adjusting age, gen-
der and BMI as confounding factors by logistic regres-
sion. Quantitative traits with skewed distribution were
natural logarithmically transformed to approximate uni-
variate normality. Quantitative traits were analyzed under
an additive genetic model by linear regression adjusted
for age, sex, and BMI. All statistical analyses were per-
formed by SAS (version 8.0; SAS Institute Inc., Cary, NC,
USA) unless specified otherwise. A two-tailed P value
<0.05 was considered significant. The allele frequencies
in HapMap populations and statistic power of the SNPs
were shown in the Additional file 2 Table S2.
Results
A total of 18 SNPs were successfully genotyped in 3,629
individuals in the present study. The LD pattern of
these SNPs was shown in Figure 1. Three haplotype
blocks were constructed in this region.
The single SNP association analysis showed that no
SNP was significantly associated with type 2 diabetes in
our samples. The minimum P value was 0.0954 for
rs10799941. Logistic regression analysis adjusting age,
gender and BMI as confounding factors also suggested
no association between SNPs and type 2 diabetes
(Table 1). For the haplotype analysis, we compared the
haplotype distributions between cases and controls and
observed that no haplotype was nominally associated
with type 2 diabetes (Table 2).
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quantitative traits related to glucose metabolism in the
individuals with normal glucose regulation. No SNP was
associated with plasma glucose and serum insulin levels
at fasting status as well as 2-h after glucose stimulation.
No significant association was detected between insulin
sensitivity and beta cell function either (Table 3).
Discussion
Genome-wide linkage studies in various populations
suggested the existence of multiple susceptibility gene(s)
for type 2 diabetes at chromosome 1q21-q24 [2-9]. Sev-
eral specific genes in this region, such as LMNA,
NOS1AP and ATF6, were identified that they might con-
fer risk for diabetes in some populations [12-16,22-24].
Figure 1 Linkage disequilibrium plots for SNPs genotyped in DUSP12 - ATF6 locus in the Chinese samples. Shades of pink indicate the
strength of pairwise LD based on |D’|. Number shown are |D’| of each SNP pair.
Table 1 Allele frequencies and association to type 2 diabetes for SNPs in the DUSP12-ATF6 locus
Gene SNP Chromosome position Major/minor allele Risk allele Risk allele frequency OR (95%CI) Pallele Pgenotype
Cases Controls
DUSP12 rs10799941 159974818 T,G T 0.540 0.520 1.0821(0.9863-1.1873) 0.0954 0.1122
DUSP12 rs1503814 159975743 C,T T 0.329 0.316 1.0613(0.9616-1.1714) 0.2373 0.3788
DUSP12 rs12021510 159975835 A,G A 0.930 0.929 1.0141(0.8466-1.2147) 0.8794 0.9472
DUSP12 rs12121310 159985839 A,C C 0.379 0.367 1.0546(0.9572-1.1620) 0.2823 0.5793
DUSP12 rs1063178 159988331 C,T T 0.460 0.458 1.0074(0.9177-1.1060) 0.8766 0.7165
DUSP12 rs1063179 159988828 C,T C 0.772 0.762 1.0594(0.9498-1.1817) 0.3002 0.3300
DUSP12 rs3820449 159993796 C,T C 0.694 0.694 1.0002(0.9049-1.1056) 0.9964 0.6854
ATF6 rs2070151 160014680 C,T T 0.311 0.300 1.0512(0.9511-1.1619) 0.3282 0.2568
ATF6 rs2271013 160020426 A,G G 0.310 0.300 1.0506(0.9505-1.1612) 0.3338 0.2515
ATF6 rs2271012 160020465 C,T T 0.317 0.302 1.0706(0.9666-1.1858) 0.1908 0.1373
ATF6 rs2070150 160027900 G,C C 0.312 0.301 1.0568(0.9559-1.1685) 0.2805 0.2015
ATF6 rs1135983 160027936 C,T T 0.309 0.297 1.0563(0.9553-1.1680) 0.2856 0.2305
ATF6 rs10918029 160062520 G,A G 0.780 0.774 1.0360(0.9272-1.1575) 0.5326 0.6230
ATF6 rs2340721 160116009 A,C C 0.349 0.344 1.0197(0.9247-1.1244) 0.6959 0.9399
ATF6 rs2341475 160145232 G,A G 0.658 0.646 1.0531(0.9497-1.1677) 0.3268 0.4704
ATF6 rs10918215 160166355 A,G G 0.432 0.427 1.0223(0.9304-1.1234) 0.6460 0.4317
ATF6 rs7522210 160193803 C,G G 0.433 0.427 1.0258(0.9341-1.1264) 0.5940 0.3425
ATF6 rs2499855 160196385 A,G A 0.897 0.890 1.0753(0.9203-1.2563) 0.3606 0.5117
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biological function in endoplasmic reticulum stress and
unfolded protein response, which linked insulin demand
with beta cell failure and diabetes. ATF6 is also the
binding target of WFS1, a known type 2 diabetes sus-
ceptible gene, and mediates its effect on endoplasmic
reticulum stress [25]. However, although we performed
the association study by analyzing 18 SNPs in 3700 Chi-
nese Han, we failed to find any evidence of association
b e t w e e nS N P sf r o mt h i sl o c u sa n dt r a i t sr e l a t e dt og l u -
cose metabolism in our samples. One possible explana-
tion might be that the statistical power of our samples
was not enough to detect the effects of this locus in the
Chinese population. Although we had over 80% power
to detect the association at the 0.05 level based on the
previously reported ORs in non-Asian populations (1.2
~ 1.3) and allele frequencies of reported SNPs in our
C h i n e s es a m p l e s ,w ec o u l dn o te x c l u d et h ep o s s i b i l i t y
the reported effect size was overestimated due to the
“winner’sc u r s e ” effect or novel associated SNPs with
lower minor allele frequencies in the Chinese existed, in
this case our samples may not have sufficient power.
Secondly, the relatively loose criteria for tagging SNP
selection, which is the limitation of the current study,
missed information for a group of SNPs in this region.
As we used r
2 over 0.7 and minor allele frequency over
0.1 as SNPs selection criterion, we failed to capture 15
(6.8%) SNPs if the stringent criterion r
2 over 0.8 and
minor allele frequency over 0.05 was adopted. Thirdly,
the LD pattern and allele frequencies differed between
Chinese Hans and previously studied populations, which
suggested population differences in the genetic architec-
ture between Chinese and other ethnic populations, may
also partly explain the lack of association between this
locus and previously reported phenotypes. Finally we
cannot exclude the possibility that rare variants within
Table 3 Association between SNPs from DUSP12-ATF6 and clinical features related to glucose metabolism in the
normal glucose regulation subjects
SNP Fasting glucose 2 h glucose Fasting insulin HOMA-IR HOMA-B
Beta SE P Beta SE P Beta SE P Beta SE P Beta SE P
rs10799941 0.0065 0.0164 0.6933 0.0325 0.0387 0.4024 -0.0087 0.0226 0.7019 -0.0076 0.0237 0.7492 -0.0164 0.0249 0.5116
rs1503814 0.0098 0.0179 0.5833 0.0247 0.0425 0.5613 0.0023 0.0251 0.9273 0.0065 0.0262 0.8036 -0.0135 0.0277 0.6264
rs12021510 0.0073 0.0322 0.8203 -0.0795 0.0760 0.2953 0.0039 0.0452 0.9319 0.0054 0.0473 0.9086 -0.0021 0.0499 0.9670
rs12121310 0.0288 0.0173 0.0963 0.0740 0.0411 0.0719 -0.0066 0.0241 0.7858 0.0010 0.0253 0.9678 -0.0400 0.0267 0.1346
rs1063178 0.0298 0.0165 0.0722 0.0356 0.0392 0.3639 0.0083 0.0230 0.7192 0.0162 0.0240 0.5008 -0.0259 0.0254 0.3068
rs1063179 -0.0178 0.0192 0.3541 0.0082 0.0454 0.8561 -0.0241 0.0262 0.3590 -0.0258 0.0274 0.3483 -0.0090 0.0288 0.7552
rs3820449 0.0216 0.0178 0.2256 0.0739 0.0421 0.0791 -0.0179 0.0247 0.4687 -0.0113 0.0259 0.6627 -0.0489 0.0273 0.0737
rs2070151 -0.0187 0.0184 0.3094 -0.0112 0.0435 0.7970 0.0023 0.0254 0.9295 -0.0061 0.0266 0.8182 0.0328 0.0280 0.2426
rs2271013 -0.0203 0.0184 0.2704 -0.0126 0.0435 0.7728 0.0014 0.0252 0.9559 -0.0073 0.0264 0.7822 0.0330 0.0278 0.2367
rs2271012 -0.0196 0.0186 0.2934 -0.0193 0.0440 0.6615 0.0086 0.0257 0.7376 0.0004 0.0269 0.9883 0.0376 0.0285 0.1866
rs2070150 -0.0177 0.0185 0.3397 -0.0154 0.0438 0.7249 0.0062 0.0257 0.8106 -0.0020 0.0269 0.9405 0.0349 0.0283 0.2178
rs1135983 -0.0168 0.0185 0.3633 -0.0192 0.0438 0.6609 0.0128 0.0256 0.6180 0.0046 0.0268 0.8642 0.0427 0.0283 0.1314
rs10918029 0.0075 0.0197 0.7027 0.0282 0.0467 0.5451 -0.0102 0.0271 0.7066 -0.0071 0.0284 0.8029 -0.0177 0.0300 0.5561
rs2340721 -0.0023 0.0174 0.8958 0.0488 0.0410 0.2342 -0.0074 0.0239 0.7581 -0.0064 0.0250 0.7988 -0.0125 0.0264 0.6346
rs2341475 0.0202 0.0187 0.2810 -0.0207 0.0445 0.6419 0.0021 0.0257 0.9350 0.0093 0.0269 0.7299 -0.0226 0.0289 0.4332
rs10918215 0.0022 0.0167 0.8941 -0.0441 0.0396 0.2647 0.0120 0.0232 0.6054 0.0093 0.0243 0.7006 0.0193 0.0256 0.4501
rs7522210 0.0001 0.0166 0.9945 -0.0425 0.0394 0.2809 0.0095 0.0230 0.6810 0.0061 0.0241 0.8001 0.0213 0.0253 0.3991
rs2499855 0.0153 0.0266 0.5654 -0.0842 0.0630 0.1814 0.0172 0.0367 0.6391 0.0199 0.0384 0.6045 0.0023 0.0407 0.9546
Table 2 Association analyses of haplotypes in DUSP12-
ATF6 locus with type 2 diabetes
Haplotype Haplotype frequencies P value
Cases Controls
Block 1 (rs10799941-rs1503814)
GC 0.449 0.467 0.1199
TT 0.318 0.304 0.1919
TC 0.222 0.217 0.5799
GT 0.011 0.013 0.5919
Block 2 (rs12021510-rs12121310-rs1063178-rs1063179-rs3820449)
ACTCT 0.307 0.306 0.8928
AACCC 0.242 0.236 0.5579
AACTC 0.228 0.237 0.3592
AATCC 0.080 0.089 0.1618
GACCC 0.070 0.069 0.8911
ACTCC 0.074 0.064 0.0897
Block 3 (rs2070151-rs10918029-rs7522210-rs2499855)
CGCA 0.342 0.341 0.9407
TGGA 0.304 0.296 0.4348
CACA 0.218 0.226 0.3917
CGGG 0.100 0.107 0.3166
CGGA 0.021 0.017 0.3030
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as we only focused on the common ones.
Conclusion
Our data suggests common variants within DUSP12 and
ATF6 genes may not play a major role in glucose meta-
bolism in the Chinese. However, due to the limitation of
the current study, the effects of SNPs from this locus on
type 2 diabetes need to be tested in further studies with
larger East Asian origin samples and higher marker
density.
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